0JZ

AFFLUENT MEDICAL SAS EO 1

Healthcare · EUR · F

0JZ

Price

€3.13

+2.62%

Cap

€187.08M

Earnings

30d Trend

+3.8%

0JZ
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

104% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level76
Quality37
Momentum88
Technical58
Fundamentals15

Raw weighted: 56×Macro 0.99 (1%)=55

RISK

76/100
90d Volatility
104.0%High
ATR %
3.5%High daily moves
Max Drawdown (1Y)
-34.4%Volatile

QUALITY

37/100
ROE (avg)
-62.5%*Negative
Piotroski F-Score
4/9Average
Accruals
-5.6%Cash earnings

MOMENTUM

88/100
12-1M Momentum
+107.9%Strong uptrend
6-1M Momentum
+94.0%Positive
1M Return
+10.6%Strong recent gains

TECHNICAL

58/100
RSI (14)
53.4Neutral
Price vs SMA200
+42.9%Bullish trend
MACD
+0.01Bullish momentum
Bollinger Band
69%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.139Noisy/choppy

FUNDAMENTALS

15/100
P/S
207.9Expensive

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months61
3-12 months67
1-5+ years35

6-9 month opportunity — emerging trend

BRAIN47'S ASSESSMENT

I rate AFFLUENT MEDICAL SAS EO 1 at 55/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 88/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+10.6%

3 MONTHS

-12.9%

12 MONTHS

+118.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month opportunity — emerging trend. Momentum (88) and Technical (58) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 104%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 55/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.